bf/NASDAQ:ASND_icon.jpeg

NASDAQ:ASND

Ascendis Pharma

  • Stock

USD

Last Close

199.28

06/11 21:00

Market Cap

7.78B

Beta: 0.55

Volume Today

927.68K

Avg: 589.77K

PE Ratio

−12.46

PFCF: −13.16

OverviewFinancialsAPI

    Description

    Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon C...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -4-3-2-11232018-05-302020-04-012022-03-022023-09-052024-11-05

    Revenue (Estimate*)

    50M100M150M200M2018-05-302020-04-012022-03-022023-09-052024-11-05

    *Estimate based on analyst consensus